MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Prima BioMed Ltd Company Profile (NASDAQ:PBMD)

Consensus Ratings for Prima BioMed Ltd (NASDAQ:PBMD) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.00 (380.77% upside)

Analysts' Ratings History for Prima BioMed Ltd (NASDAQ:PBMD)
Show:
DateFirmActionRatingPrice TargetActions
5/12/2016Maxim GroupBoost Price TargetBuy$4.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016HC WainwrightReiterated RatingBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016FBR & Co.Reiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2015Roth CapitalInitiated CoverageBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha